Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Xq12-q13.3 duplication syndrome is a rare chromosomal anomaly syndrome, resulting from the partial duplication of the long arm of chromosome X, characterized by global developmental delay, autistic behavior, microcephaly and facial dysmorphism (including down-slanting palpebral fissures, depressed nasal bridge, anteverted nares, long philtrum, down-slanting corners of the mouth). Seizures have also been reported in some patients.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Xq12-q13.3 duplication syndrome.
1 publication has been identified in PubMed for Xq12-q13.3 duplication syndrome. Research spans Review / Meta-Analysis (100%).
Ogunbileje JO (2024). [PMID: 38929857](https://pubmed.ncbi.nlm.nih.gov/38929857/). *J Pers Med*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 3:00 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Xq12-q13.3 duplication syndrome